PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-5.68%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
9.32%
Positive gross profit growth while ADI is negative. John Neff would see a clear operational edge over the competitor.
43.39%
EBIT growth 75-90% of ADI's 53.44%. Bill Ackman would push for cost reforms or better product mix to narrow the gap.
33.50%
Operating income growth at 50-75% of ADI's 53.44%. Martin Whitman would doubt the firm’s ability to compete efficiently.
15.24%
Positive net income growth while ADI is negative. John Neff might see a big relative performance advantage.
20.00%
Positive EPS growth while ADI is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
20.00%
Positive diluted EPS growth while ADI is negative. John Neff might view this as a strong relative advantage in controlling dilution.
45.37%
Share count expansion well above ADI's 5.21%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
42.90%
Diluted share count expanding well above ADI's 16.61%. Michael Burry would fear significant dilution to existing owners' stakes.
-33.23%
Dividend reduction while ADI stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-24.69%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-19.83%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-33.03%
Negative 10Y revenue/share CAGR while ADI stands at 103.04%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-57.43%
Negative 5Y CAGR while ADI stands at 45.36%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-63.08%
Negative 3Y CAGR while ADI stands at 64.46%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
No Data
No Data available this quarter, please select a different quarter.
-37.86%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-46.80%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
12.76%
10Y net income/share CAGR of 12.76% while ADI is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
-27.94%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-56.65%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
115.41%
10Y equity/share CAGR at 50-75% of ADI's 184.36%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
42.97%
Below 50% of ADI's 150.05%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
6.40%
Below 50% of ADI's 167.60%. Michael Burry suspects a serious short-term disadvantage in building book value.
29.25%
Dividend/share CAGR of 29.25% while ADI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
-1.57%
Negative 5Y dividend/share CAGR while ADI stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-33.25%
Negative near-term dividend growth while ADI invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-2.35%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
8.42%
Inventory growth well above ADI's 0.99%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
6.96%
Asset growth above 1.5x ADI's 1.07%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
-25.51%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-1.07%
We’re deleveraging while ADI stands at 0.42%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-3.44%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
5.47%
We expand SG&A while ADI cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.